This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Endtz, H. P.
Right arrow Articles by van Belkum, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Endtz, H. P.
Right arrow Articles by van Belkum, A.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, June 2000, p. 2297-2301, Vol. 38, No. 6
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Molecular Characterization of Campylobacter jejuni from Patients with Guillain-Barré and Miller Fisher Syndromes

Hubert P. Endtz,1,* C. Wim Ang,2 Nicole van den Braak,1 Birgitta Duim,3 Alan Rigter,3 Lawrence J. Price,4 David L. Woodward,4 Frank G. Rodgers,4 Wendy M. Johnson,4 Jaap A. Wagenaar,3 Bart C. Jacobs,2 Henri A. Verbrugh,1 and Alex van Belkum1

Departments of Medical Microbiology & Infectious Diseases1 and Neurology and Immunology,2 Erasmus University Medical Center Rotterdam, Rotterdam, and DLO-Institute for Animal Science and Health, Lelystad,3 The Netherlands, and National Laboratory for Enteric Pathogens, Canadian Science Centre for Human and Animal Health, LCDC, Winnipeg, Canada4

Received 15 November 1999/Returned for modification 9 March 2000/Accepted 27 March 2000

Campylobacter jejuni has been identified as the predominant cause of antecedent infection in Guillain-Barré syndrome (GBS) and Miller Fisher syndrome (MFS). The risk of developing GBS or MFS may be higher after infection with specific C. jejuni types. To investigate the putative clonality, 18 GBS- or MFS-related C. jejuni strains from The Netherlands and Belgium and 17 control strains were analyzed by serotyping (Penner and Lior), restriction fragment length polymorphism analysis of PCR products of the flaA gene, amplified fragment length polymorphism analysis, pulsed-field gel electrophoresis, and randomly amplified polymorphic DNA analysis. Serotyping revealed 10 different O serotypes and 7 different Lior serotypes, thereby indicating a lack of serotype clustering. Two new O serotypes, O:35 and O:13/65, not previously associated with GBS or MFS were found. Serotype O:19 was encountered in 2 of 18 strains, and none was of serotype O:41. The results of all genotypic methods also demonstrated substantial heterogeneity. No clustering of GBS- or MFS-related strains occurred and no molecular marker capable of separating pathogenic GBS or MFS from non-GBS- or non-MFS-related enteritis strains could be identified in this study. Sialic-acid-containing lipopolysaccharides (LPS) are thought to be involved in the triggering of GBS or MFS through molecular mimicry with gangliosides in human peripheral nerves. Therefore, further characterization of GBS- or MFS-related C. jejuni should target the genes involved in the synthesis of LPS and the incorporation of sialic acid.

* Corresponding author. Mailing address: Department of Medical Microbiology & Infectious Diseases, Erasmus University Medical Center Rotterdam, Dr Molewaterplein 40, 3015 GD Rotterdam, The Netherlands. Phone: (31) 10 4635820. Fax: (31) 10 4633875. E-mail: ENDTZ{at}BACL.AZR.NL.

Journal of Clinical Microbiology, June 2000, p. 2297-2301, Vol. 38, No. 6
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Gaasbeek, E. J., Wagenaar, J. A., Guilhabert, M. R., Wosten, M. M. S. M., van Putten, J. P. M., van der Graaf-van Bloois, L., Parker, C. T., van der Wal, F. J. (2009). A DNase Encoded by Integrated Element CJIE1 Inhibits Natural Transformation of Campylobacter jejuni. J. Bacteriol. 191: 2296-2306 [Abstract] [Full Text]  
  • Cheng, J., Yu, H., Lau, K., Huang, S., Chokhawala, H. A, Li, Y., Tiwari, V. K., Chen, X. (2008). Multifunctionality of Campylobacter jejuni sialyltransferase CstII: Characterization of GD3/GT3 oligosaccharide synthase, GD3 oligosaccharide sialidase, and trans-sialidase activities. Glycobiology 18: 686-697 [Abstract] [Full Text]  
  • Nachamkin, I., Barbosa, P. A., Ung, H., Lobato, C., Rivera, A. G., Rodriguez, P., Briseno, A. G., Cordero, L. M., Perea, L. G., Perez, J. C., Ribera, M., Veitch, J., Fitzgerald, C., Cornblath, D., Pinto, M. R., Griffin, J. W., Willison, H. J., Asbury, A. K., McKhann, G. M. (2007). Patterns of Guillain-Barre syndrome in children: Results from a Mexican population. Neurology 69: 1665-1671 [Abstract] [Full Text]  
  • Godschalk, P. C. R., Kuijf, M. L., Li, J., St. Michael, F., Ang, C. W., Jacobs, B. C., Karwaski, M.-F., Brochu, D., Moterassed, A., Endtz, H. P., van Belkum, A., Gilbert, M. (2007). Structural Characterization of Campylobacter jejuni Lipooligosaccharide Outer Cores Associated with Guillain-Barre and Miller Fisher Syndromes. Infect. Immun. 75: 1245-1254 [Abstract] [Full Text]  
  • Koga, M., Takahashi, M., Masuda, M., Hirata, K., Yuki, N. (2005). Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barre syndrome. Neurology 65: 1376-1381 [Abstract] [Full Text]  
  • Snelling, W. J., McKenna, J. P., Lecky, D. M., Dooley, J. S. G. (2005). Survival of Campylobacter jejuni in Waterborne Protozoa. Appl. Environ. Microbiol. 71: 5560-5571 [Abstract] [Full Text]  
  • Tu, Z.-C., Eisner, W., Kreiswirth, B. N., Blaser, M. J. (2005). Genetic Divergence of Campylobacter fetus Strains of Mammal and Reptile Origins. J. Clin. Microbiol. 43: 3334-3340 [Abstract] [Full Text]  
  • Takahashi, M., Koga, M., Yokoyama, K., Yuki, N. (2005). Epidemiology of Campylobacter jejuni Isolated from Patients with Guillain-Barre and Fisher Syndromes in Japan. J. Clin. Microbiol. 43: 335-339 [Abstract] [Full Text]  
  • Gilbert, M., Godschalk, P. C. R., Karwaski, M.-F., Ang, C. W., van Belkum, A., Li, J., Wakarchuk, W. W., Endtz, H. P. (2004). Evidence for Acquisition of the Lipooligosaccharide Biosynthesis Locus in Campylobacter jejuni GB11, a Strain Isolated from a Patient with Guillain-Barre Syndrome, by Horizontal Exchange. Infect. Immun. 72: 1162-1165 [Abstract] [Full Text]  
  • Endtz, H. P., van West, H., Godschalk, P. C. R., de Haan, L., Halabi, Y., van den Braak, N., Kesztyus, B. I., Leyde, E., Ott, A., Verkooyen, R., Price, L. J., Woodward, D. L., Rodgers, F. G., Ang, C. W., van Koningsveld, R., van Belkum, A., Gerstenbluth, I. (2003). Risk Factors Associated with Campylobacter jejuni Infections in Curacao, Netherlands Antilles. J. Clin. Microbiol. 41: 5588-5592 [Abstract] [Full Text]  
  • Schouls, L. M., Reulen, S., Duim, B., Wagenaar, J. A., Willems, R. J. L., Dingle, K. E., Colles, F. M., Van Embden, J. D. A. (2003). Comparative Genotyping of Campylobacter jejuni by Amplified Fragment Length Polymorphism, Multilocus Sequence Typing, and Short Repeat Sequencing: Strain Diversity, Host Range, and Recombination. J. Clin. Microbiol. 41: 15-26 [Abstract] [Full Text]  
  • Ge, B., Bodeis, S., Walker, R. D., White, D. G., Zhao, S., McDermott, P. F., Meng, J. (2002). Comparison of the Etest and agar dilution for in vitro antimicrobial susceptibility testing of Campylobacter. J Antimicrob Chemother 50: 487-494 [Abstract] [Full Text]  
  • Nachamkin, I., Liu, J., Li, M., Ung, H., Moran, A. P., Prendergast, M. M., Sheikh, K. (2002). Campylobacter jejuni from Patients with Guillain-Barre Syndrome Preferentially Expresses a GD1a-Like Epitope. Infect. Immun. 70: 5299-5303 [Abstract] [Full Text]  
  • Ang, C. W., Laman, J. D., Willison, H. J., Wagner, E. R., Endtz, H. P., De Klerk, M. A., Tio-Gillen, A. P., Van den Braak, N., Jacobs, B. C., Doorn, P. A. V. (2002). Structure of Campylobacter jejuni Lipopolysaccharides Determines Antiganglioside Specificity and Clinical Features of Guillain-Barre and Miller Fisher Patients. Infect. Immun. 70: 1202-1208 [Abstract] [Full Text]  
  • (2002). Molecular typing of micro-organisms: at the centre of diagnostics, genomics and pathogenesis of infectious diseases?. J Med Microbiol 51: 7-10 [Full Text]  
  • Dingle, K. E., Van Den Braak, N., Colles, F. M., Price, L. J., Woodward, D. L., Rodgers, F. G., Endtz, H. P., Van Belkum, A., Maiden, M. C. J. (2001). Sequence Typing Confirms that Campylobacter jejuni Strains Associated with Guillain-Barre and Miller-Fisher Syndromes Are of Diverse Genetic Lineage, Serotype, and Flagella Type. J. Clin. Microbiol. 39: 3346-3349 [Abstract] [Full Text]  
  • Prendergast, M. M., Kosunen, T. U., Moran, A. P. (2001). Development of an Immunoassay for Rapid Detection of Ganglioside GM1 Mimicry in Campylobacter jejuni Strains. J. Clin. Microbiol. 39: 1494-1500 [Abstract] [Full Text]  
  • Duim, B., Ang, C. W., van Belkum, A., Rigter, A., van Leeuwen, N. W. J., Endtz, H. P., Wagenaar, J. A. (2000). Amplified Fragment Length Polymorphism Analysis of Campylobacter jejuni Strains Isolated from Chickens and from Patients with Gastroenteritis or Guillain-Barre or Miller Fisher Syndrome. Appl. Environ. Microbiol. 66: 3917-3923 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»